AG
CRL icon

AmeriFlex Group’s Charles River Laboratories CRL Stock Holding History

AmeriFlex Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81K Buy
+8
New +$1.43K ﹤0.01% 1292
2026
Q1 		– Sell
-34
Closed -$6.78K – 1133
2025
Q4 		$6.78K Sell
34
-34
-50% -$6.17K ﹤0.01% 787
2025
Q3 		$10.6K Buy
+68
New +$10.8K ﹤0.01% 768

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

AmeriFlex Group's CRL Position: Q2 2026 in Review

AmeriFlex Group opened a new position in Charles River Laboratories (CRL) in Q2 2026: 8 shares worth $1.81K. The stake represents ﹤0.01% of the portfolio and ranks #1292 among its holdings. This is a return to the name: AmeriFlex Group previously reported a position in CRL as recently as Q4 2025.

AmeriFlex Group first reported a position in CRL in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.6K in Q3 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • AmeriFlex Group held 8 shares of Charles River Laboratories worth $1.81K as of Q2 2026.
  • Charles River Laboratories was a new AmeriFlex Group position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1292 holding.
  • AmeriFlex Group first reported a position in Charles River Laboratories in Q3 2025 and has held it in 3 quarters since.
  • AmeriFlex Group's Charles River Laboratories position peaked at $10.6K in Q3 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.